during the promptly evolving subject of oncology study, accurate and effective mutation screening is essential for developing qualified therapies. The KRAS products and services Platform performs a pivotal function On this landscape by giving comprehensive methods for KRAS mutation profiling and Assessment. KRAS mutations, found in somewhere around